Beth Chopp

Beth Chopp, PhD, currently serves as the Lead Medical Science Liaison at C2N Diagnostics since October 2023. Prior to this role, Beth held the position of Director, Medical Science Liaison at BioXcel Therapeutics, Inc. from June 2022 to October 2023 and served as Senior Medical Science Liaison for Alzheimer's Disease at Biogen from May 2020 to June 2022. Earlier in the career, Beth worked as Medical Science Liaison Associate Director for Neuroscience at Novartis from January 2018 to May 2020, and as a Neuroscience Medical Science Liaison at Eli Lilly and Company from February 1998 to December 2017. The career began at Wyeth Ayerst Laboratories as Psychiatry Specialty Manager from January 1989 to February 1998, followed by a position as OB/Neonatal Nutritionist at Penn Medicine, University of Pennsylvania Health System from March 1986 to October 1989. Beth Chopp earned a Doctor of Philosophy in Health Services Research from Old Dominion University between 2013 and 2019, a Masters in Health Education from Saint Joseph's University from 1988 to 1992, and a Bachelor's degree in Dietetics and Clinical Nutrition Services from Drexel University from 1980 to 1984.